2022 Q1 Form 10-Q Financial Statement

#000149315222013777 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $10.78M $7.625M
YoY Change 41.43% -9.55%
Cost Of Revenue $6.971M $4.917M
YoY Change 41.79% -10.28%
Gross Profit $3.812M $2.708M
YoY Change 40.77% -8.19%
Gross Profit Margin 35.35% 35.52%
Selling, General & Admin $1.394M $1.254M
YoY Change 11.18% -4.33%
% of Gross Profit 36.57% 46.3%
Research & Development $17.70K $18.28K
YoY Change -3.17% -36.05%
% of Gross Profit 0.46% 0.67%
Depreciation & Amortization $188.4K $184.9K
YoY Change 1.91% 84.95%
% of Gross Profit 4.94% 6.83%
Operating Expenses $1.481M $1.343M
YoY Change 10.29% -2.9%
Operating Profit $2.331M $1.365M
YoY Change 70.74% -12.86%
Interest Expense $57.62K $62.27K
YoY Change -7.48% -38.6%
% of Operating Profit 2.47% 4.56%
Other Income/Expense, Net
YoY Change
Pretax Income $2.390M $2.123M
YoY Change 12.6% 20.14%
Income Tax $712.5K $485.5K
% Of Pretax Income 29.81% 22.87%
Net Earnings $1.533M $1.451M
YoY Change 5.69% 14.7%
Net Earnings / Revenue 14.22% 19.02%
Basic Earnings Per Share $0.12 $0.12
Diluted Earnings Per Share $122.2K $115.9K
COMMON SHARES
Basic Shares Outstanding 12.36M shares 12.29M shares
Diluted Shares Outstanding 12.54M shares 12.52M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.372M $1.854M
YoY Change 189.8% -45.68%
Cash & Equivalents $5.372M $1.854M
Short-Term Investments
Other Short-Term Assets $1.885M $1.243M
YoY Change 51.64% 311.34%
Inventory $12.21M $9.989M
Prepaid Expenses $859.9K $243.2K
Receivables $9.943M $7.539M
Other Receivables $0.00 $0.00
Total Short-Term Assets $29.41M $20.63M
YoY Change 42.61% 1.65%
LONG-TERM ASSETS
Property, Plant & Equipment $4.920M $5.053M
YoY Change -2.64% 26.76%
Goodwill $2.534M $2.534M
YoY Change 0.0% 0.0%
Intangibles $2.560M $2.732M
YoY Change -6.3% -6.05%
Long-Term Investments $5.453M $4.973M
YoY Change 9.67% 77.64%
Other Assets $12.70K $299.6K
YoY Change -95.76% -80.61%
Total Long-Term Assets $15.70M $16.03M
YoY Change -2.07% 10.36%
TOTAL ASSETS
Total Short-Term Assets $29.41M $20.63M
Total Long-Term Assets $15.70M $16.03M
Total Assets $45.12M $36.66M
YoY Change 23.07% 5.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.363M $515.5K
YoY Change 164.35% -46.63%
Accrued Expenses $1.319M $395.6K
YoY Change 233.32% 1.93%
Deferred Revenue
YoY Change
Short-Term Debt $4.949M $3.228M
YoY Change 53.28% -9.21%
Long-Term Debt Due $665.6K $837.7K
YoY Change -20.54% -30.03%
Total Short-Term Liabilities $13.90M $8.533M
YoY Change 62.87% 2.05%
LONG-TERM LIABILITIES
Long-Term Debt $1.491M $2.263M
YoY Change -34.1% -24.11%
Other Long-Term Liabilities $146.7K $184.7K
YoY Change -20.58% -40.74%
Total Long-Term Liabilities $1.491M $2.263M
YoY Change -34.1% -24.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.90M $8.533M
Total Long-Term Liabilities $1.491M $2.263M
Total Liabilities $15.85M $11.21M
YoY Change 41.3% -15.13%
SHAREHOLDERS EQUITY
Retained Earnings $10.42M $6.884M
YoY Change 51.3% 85.01%
Common Stock $12.38K $12.32K
YoY Change 0.5% 0.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.79M $22.86M
YoY Change
Total Liabilities & Shareholders Equity $45.12M $36.66M
YoY Change 23.07% 5.29%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $1.533M $1.451M
YoY Change 5.69% 14.7%
Depreciation, Depletion And Amortization $188.4K $184.9K
YoY Change 1.91% 84.95%
Cash From Operating Activities -$2.425M -$2.357M
YoY Change 2.9% 104.24%
INVESTING ACTIVITIES
Capital Expenditures $176.7K $96.14K
YoY Change 83.79% -0.15%
Acquisitions
YoY Change
Other Investing Activities $7.500K $12.50K
YoY Change -40.0% -101.73%
Cash From Investing Activities -$169.2K -$83.64K
YoY Change 102.29% -89.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $56.94K $76.36K
YoY Change -25.43% 208.53%
Debt Paid & Issued, Net $209.6K $208.9K
YoY Change 0.37% 3.89%
Cash From Financing Activities $2.213M $738.8K
YoY Change 199.53% -0.89%
NET CHANGE
Cash From Operating Activities -$2.425M -$2.357M
Cash From Investing Activities -$169.2K -$83.64K
Cash From Financing Activities $2.213M $738.8K
Net Change In Cash -$338.6K -$1.619M
YoY Change -79.09% 32.46%
FREE CASH FLOW
Cash From Operating Activities -$2.425M -$2.357M
Capital Expenditures $176.7K $96.14K
Free Cash Flow -$2.602M -$2.453M
YoY Change 6.07% 96.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001069394
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 FSI Ppp Loan Forgiveness
PppLoanForgiveness
usd
CY2022Q1 FSI Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
usd
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2021 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
usd
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
usd
CY2022Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
usd
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-31540
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
FLEXIBLE SOLUTIONS INTERNATIONAL INC.
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
71-1630889
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6001 54 Ave.
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Taber
CY2022Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
T1G 1X4
CY2022Q1 dei City Area Code
CityAreaCode
(403)
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
223-2995
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
FSI
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12377246 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5371608 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5710227 usd
CY2022Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1025347 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1025347 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9943148 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7129329 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
12214651 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
9502005 usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
859922 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
442161 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
29414676 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
23809069 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4920019 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4931713 usd
CY2022Q1 FSI Finite Lived Patent Gross
FiniteLivedPatentGross
9589 usd
CY2021Q4 FSI Finite Lived Patent Gross
FiniteLivedPatentGross
13699 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
203721 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
217267 usd
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2560000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2600000 usd
CY2022Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
5453274 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
5424010 usd
CY2022Q1 us-gaap Goodwill
Goodwill
2534275 usd
CY2021Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12697 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12697 usd
CY2022Q1 us-gaap Assets
Assets
45116791 usd
CY2021Q4 us-gaap Assets
Assets
39551270 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1362779 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1283486 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1318503 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
457062 usd
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
271426 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
349004 usd
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
5273842 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4561396 usd
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4948545 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2300819 usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57045 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77715 usd
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
665614 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
793574 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13897754 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9823056 usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
146676 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
139552 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
310162 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
310162 usd
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1491355 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1573024 usd
CY2022Q1 us-gaap Liabilities
Liabilities
15845947 usd
CY2021Q4 us-gaap Liabilities
Liabilities
11845794 usd
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12377746 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12377746 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12355246 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12355246 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
12378 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12355 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
12378 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12355 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17094836 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16983648 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-733187 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-775730 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10415419 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8882360 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
26789446 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25102633 usd
CY2022Q1 us-gaap Minority Interest
MinorityInterest
2481398 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
2602843 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
29270844 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27705476 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45116791 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39551270 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10783280 usd
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7624697 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6971379 usd
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4916776 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
3811901 usd
CY2021Q1 us-gaap Gross Profit
GrossProfit
2707921 usd
CY2022Q1 us-gaap Salaries And Wages
SalariesAndWages
623503 usd
CY2021Q1 us-gaap Salaries And Wages
SalariesAndWages
579355 usd
CY2022Q1 us-gaap Officers Compensation
OfficersCompensation
233585 usd
CY2021Q1 us-gaap Officers Compensation
OfficersCompensation
222490 usd
CY2022Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
185360 usd
CY2021Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
124458 usd
CY2022Q1 FSI Consulting
Consulting
76274 usd
CY2021Q1 FSI Consulting
Consulting
72961 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
57618 usd
CY2021Q1 us-gaap Interest Expense
InterestExpense
62274 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
50581 usd
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
53689 usd
CY2022Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
44808 usd
CY2021Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
10994 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
42225 usd
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
66028 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
40029 usd
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34770 usd
CY2022Q1 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
37097 usd
CY2021Q1 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
25087 usd
CY2022Q1 us-gaap Other General Expense
OtherGeneralExpense
35970 usd
CY2021Q1 us-gaap Other General Expense
OtherGeneralExpense
42119 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17696 usd
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18275 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11533 usd
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8300 usd
CY2022Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
9456 usd
CY2021Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
9991 usd
CY2022Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
7618 usd
CY2021Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
2722 usd
CY2022Q1 FSI Shipping Cost
ShippingCost
3994 usd
CY2021Q1 FSI Shipping Cost
ShippingCost
4355 usd
CY2022Q1 FSI Commissions
Commissions
3424 usd
CY2021Q1 FSI Commissions
Commissions
4768 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1480771 usd
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
1342636 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2331130 usd
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1365285 usd
CY2021Q1 FSI Ppp Loan Forgiveness
PppLoanForgiveness
537960 usd
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
36764 usd
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
208968 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
22088 usd
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
10298 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2389982 usd
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2122511 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
712446 usd
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
485456 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1677536 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1637055 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
144477 usd
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
186484 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1533059 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1450571 usd
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12361313 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12292452 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12543674 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12518331 shares
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1677536 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1637055 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
42543 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
82352 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1720079 usd
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1719407 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
144477 usd
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
186484 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1575602 usd
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1532923 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1677536 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1637055 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
54271 usd
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
39589 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
232488 usd
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
232965 usd
CY2022Q1 FSI Lease Right Of Use Financing
LeaseRightOfUseFinancing
2539 usd
CY2021Q1 FSI Lease Right Of Use Financing
LeaseRightOfUseFinancing
8187 usd
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13546 usd
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
74884 usd
CY2022Q1 FSI Gain Loss On Investment
GainLossOnInvestment
36764 usd
CY2021Q1 FSI Gain Loss On Investment
GainLossOnInvestment
208968 usd
CY2021Q1 FSI Paycheck Protection Program Loan Forgiveness
PaycheckProtectionProgramLoanForgiveness
537960 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2813819 usd
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1649501 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2712646 usd
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1616862 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
417761 usd
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-59204 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
940734 usd
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-872823 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
712446 usd
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
513323 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-77578 usd
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-35860 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2425008 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2356767 usd
CY2022Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
7500 usd
CY2021Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
12500 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176684 usd
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96136 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-169184 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83636 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2647726 usd
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1112361 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
209629 usd
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
208857 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
16085 usd
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
83070 usd
CY2022Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
265922 usd
CY2021Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
157952 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56940 usd
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
76360 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2213030 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
738842 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42543 usd
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
82352 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-338619 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1619209 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6735574 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4472776 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6396955 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2853567 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5371608 usd
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1853567 usd
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
1025347 usd
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
1000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6396955 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2853567 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
57618 usd
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
62274 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27705476 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
42543 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1677536 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
56940 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
265922 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54271 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
29270844 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23768279 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23768279 usd
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
82352 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1637055 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
76360 usd
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
157952 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39589 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25445683 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25445683 usd
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zxQ2QUZm2xy2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zag42A8Qtt15"><i>Risk Management</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties. Revenue for the Company’s three primary customers totaled $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zsGFNgC1XJhd" title="Revenue from Contract with Customer, Excluding Assessed Tax">6,235,661</span> (<span id="xdx_902_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z44u7ROVWdK" title="Concentration risk threshold percentage">58</span>%) for the three months ended March 31, 2022 (2021 - $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zPGa42MgqE27">3,120,819</span> or <span id="xdx_906_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zlTemFAhyxp4">41</span>%). Accounts receivable for the Company’s three primary customers totaled $<span id="xdx_908_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zeL30PeqvdLa">6,367,303</span> (<span id="xdx_909_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zygXz6MiRDW7" title="Accounts Receivable, after Allowance for Credit Loss">64</span>%) at March 31, 2022 (December 31, 2021 - $<span id="xdx_908_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_z1Z7mjFukIJa" title="Accounts Receivable, after Allowance for Credit Loss">4,940,995</span> or <span id="xdx_90B_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zRBi7vzHhjf">69</span>%).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit risk on cash and cash equivalents is limited because the Company limits its exposure to credit loss by placing its cash and cash equivalents with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to foreign exchange and interest rate risk to the extent that market value rate fluctuations materially differ from financial assets and liabilities, subject to fixed long-term rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to foreign exchange risks, the Company is closely monitoring the fluctuations in the foreign currency exchange rates and the impact on the value of cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to interest rate risk, the Company is closely monitoring fluctuations in market interest risks and will refinance its long-term debt where possible to obtain more favourable rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_z5vjJf7EZJgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zwrZcivJ7BJe"><i>Use of Estimates</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible assets, asset impairment analysis, share-based payments, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts receivable, recoverability of investments, discount rates for right of use assets and the valuation of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1 us-gaap Equity Method Investment Description Of Principal Activities
EquityMethodInvestmentDescriptionOfPrincipalActivities
Significant influence is generally deemed to exist if the Company’s ownership interest in the voting stock of the investee ranges between 20% and 50%, although other factors, such as representation on the investee’s board of directors, are considered in determining whether the equity method of accounting is appropriate
CY2022Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.055 pure
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
217267 usd
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
483113 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
13546 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
265846 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
203721 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
217267 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
217267 usd
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
483113 usd
CY2022Q1 FSI Lease Interest Expense
LeaseInterestExpense
2539 usd
CY2021 FSI Lease Interest Expense
LeaseInterestExpense
22057 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
16085 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
287903 usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
203721 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
217267 usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57045 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77715 usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
146676 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
139552 usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
203721 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
217267 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
42525 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
58080 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
59520 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
61020 usd
CY2022Q1 FSI Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
221145 usd
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17424 usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
203721 usd
CY2022Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
10217709 usd
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7403308 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
274561 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
273979 usd
CY2022Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
9943148 usd
CY2021Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
7129329 usd
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3816366 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3417829 usd
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
8398285 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
6084176 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
12214651 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
9502005 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12718755 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7798736 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4920019 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12538418 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7606705 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4931713 usd
CY2022Q1 us-gaap Depreciation
Depreciation
188378 usd
CY2021Q1 us-gaap Depreciation
Depreciation
184855 usd
CY2022Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
212161 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
202572 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9589 usd
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
208079 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
194380 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13699 usd
CY2022Q1 FSI Increase In Currency Conversion
IncreaseInCurrencyConversion
265102 cad
CY2021Q4 FSI Increase In Currency Conversion
IncreaseInCurrencyConversion
265102 cad
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4110 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4110 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13699 usd
CY2021Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2022Q1 us-gaap Goodwill
Goodwill
2534275 usd
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
770000 usd
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
770000 usd
CY2022Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2366598 usd
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
3847638 usd
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
537960 usd
CY2022Q1 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
206629 usd
CY2021 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
943080 usd
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
2156969 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2366598 usd
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
2156969 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2366598 usd
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
665614 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
793574 usd
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1491355 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1573024 usd
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1 pure
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
749000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.42
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
170000 shares
CY2021 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice
3.61
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.61
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
34799 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.30
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
94701 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.58
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
789500 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.78
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5000 shares
CY2022Q1 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice
3.61
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.61
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
3000 shares
CY2022Q1 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Cancelled Or Expired Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledOrExpiredOptionsExercisePrice
3.61
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.61
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22500 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.53
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
769000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.82
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
539000 shares
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.69
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0123 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6966 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6328 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.46
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.54
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2022Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2 segments
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10783280 usd
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7624697 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10783280 usd
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7624697 usd
CY2022Q1 us-gaap Noncurrent Assets
NoncurrentAssets
10227604 usd
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
10296954 usd
CY2022Q1 us-gaap Noncurrent Assets
NoncurrentAssets
10227604 usd
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
10296954 usd

Files In Submission

Name View Source Status
0001493152-22-013777-index-headers.html Edgar Link pending
0001493152-22-013777-index.html Edgar Link pending
0001493152-22-013777.txt Edgar Link pending
0001493152-22-013777-xbrl.zip Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex3-1_003.jpg Edgar Link pending
ex3-1_004.jpg Edgar Link pending
ex3-1_005.jpg Edgar Link pending
ex3-1_006.jpg Edgar Link pending
ex3-1_007.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
fsi-20220331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
fsi-20220331_cal.xml Edgar Link unprocessable
fsi-20220331_def.xml Edgar Link unprocessable
fsi-20220331_lab.xml Edgar Link unprocessable
fsi-20220331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable